RecruitingPhase 4NCT05193552
Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease
Studying OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Harry Schroeder, MD/PhDUniversity of Alabama at Birmingham
- Intervention
- Hizentra(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Community Health 20, Birmingham, Alabama, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05193552 on ClinicalTrials.govOther trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT05593588Senolytics Treatment of Interstitial Lung Disease in Common Variable ImmunodeficiencyAvni Joshi
- RECRUITINGPHASE2NCT02579967Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesNational Cancer Institute (NCI)
See all trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency →